Gliclazide and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Vimpat (lacosamide). Common drug interactions include craniocerebral injury among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Vimpat. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

On Jul, 17, 2026

13 people who take Gliclazide and Vimpat together, and have interactions are studied.

Gliclazide and Vimpat drug interactions.

What are the common drug interactions of Gliclazide and Vimpat, by gender? *:

female:

n/a

male:

Craniocerebral injury (injury to cranium and brain)
Hypersomnia (excessive daytime sleepiness (eds))
Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
Attention deficit/hyperactivity disorder
Death
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Multiple-drug resistance
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Gliclazide and Vimpat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cataplexy (loss of muscle tone accompanied by full conscious awareness)
Diarrhoea
Insomnia (sleeplessness)
Seasonal allergy (allergic condition due to certain season)
Spinal fracture (fracture in one of vertebrae)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Death
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Vomiting
Wheezing (a high-pitched whistling sound made while you breath)
Malaise (a feeling of general discomfort or uneasiness)
Multiple-drug resistance
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Rash

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 76.92%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 76.92%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 23.08%
Drowsiness: 3 people, 23.08%
Diarrhea: 2 people, 15.38%
Type 2 Diabetes: 1 person, 7.69%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Vimpat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously